在与艾滋病毒相关的神经认知衰退的研究中考虑道德和临床问题
Kayla Davis1, Krista-Gaie Grant1, John M Sousou2
1Department of Psychiatry, University of Florida College of Medicine, Gainesville, USA.
Cureus
|December 22, 2025
概括
本案例研究探讨了诊断和管理先进的艾滋病毒相关神经认知障碍 (HAND) 的复杂挑战. 它强调了耻辱和家庭冲突如何延迟护理,强调了需要综合医疗和伦理方法的必要性.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 医学伦理 医学伦理
背景情况:
- 人类免疫缺陷病毒 (HIV) 可以影响中枢神经系统,导致与HIV相关的神经认知障碍 (HAND).
- 尽管结合抗逆转录病毒疗法 (cART),神经系统并发症,如渐进的多焦点白脑病变 (PML) 和艾滋病毒脑炎 (HIVE) 持续.
- 鉴于这些疾病的不同原因,结果和治疗方法,区分这些疾病至关重要.
研究的目的:
- 描述一个复杂的先进的HIV病例与神经认知衰退.
- 为了说明临床模两可和患者护理中的伦理挑战的相互作用.
- 强调需要采用整体方法来管理与艾滋病毒有关的神经认知障碍.
主要方法:
- 一个37岁的男性未经治疗的艾滋病毒和快速认知衰退的案例报告.
- 神经成像 (T2/FLAIR MRI) 显示了白质异常.
- 认知衰退的临床评估,功能状态和治疗坚持.
主要成果:
- 患者表现为严重的认知衰退,混乱和失禁.
- 核磁共振成像结果表明PML,HIVE或高级HAND.
- 由于不坚持治疗,失能和因耻辱而导致的家庭冲突而复杂化的临床过程.
结论:
- 诊断与艾滋病毒相关的认知衰退需要整合神经成像,CSF研究和神经心理测试.
- 耻辱感,家庭动态,以及缺乏预先指示,都会阻碍及时的护理.
- 最佳的管理需要一种基于耻辱的,在伦理上敏感的方法,在生物医学治疗的同时解决心理社会障碍.
相关概念视频
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
503
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
503
01:29Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K